Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Medicare targets 15 more drugs for price negotiations
Medicare drug price negotiations to target Ozempic, Wegovy and other drugs
The hugely popular medications Ozempic and Wegovy, used for diabetes and weight loss, will be included in the next round of talks to negotiate lower Medicare drug prices.
Medicare to negotiate price of Ozempic, Wegovy weight-loss drugs
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
Explainer: What Wegovy's inclusion in Medicare price negotiation means for patients, company
The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027, which includes Novo Nordisk's blockbuster weight-loss drug Wegovy. Here's
Medicare announces 15 new drugs chosen for price negotiations, including popular weight loss drug Ozempic
Diabetes and weight loss drugs Ozempic and Wegovy have been added to the list of medications selected for Medicare price negotiations, federal health officials announced Friday. The negotiations for the 15 additional drugs, which will be handled by the incoming administration, assure major savings for Americans.
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that go into effect in 2027.
Ozempic, Wegovy are among 15 drugs selected for Medicare’s price negotiations
U.S. Health and Human Services Secretary Xavier Becerra says “this is a big deal.” Drug companies oppose the program.
Latest Medicare price drug negotiations includes Ozempic, Wegovy
Drugs used to treat cancer, diabetes and other chronic conditions are among 15 picked for negotiations that could result in lower prices for patients, the Department of Health and Human Services confirmed Friday.
15 New Drugs Selected for Medicare Price Negotiations
The bad news is people on Medicare will have to wait a while before they see the savings. Retirees could feel the economic impact of President-elect Donald Trump prepares to reclaim office in Washington,
Biden administration adds 15 drugs to Medicare price negotiation list
Medicare enrollees, however, still won’t be able to access the drugs for obesity under a federal law that prohibits the program from paying for weight loss treatments. Right now
Healthline
3d
Understanding Medicare Savings Programs: Eligibility and Enrollment
Medicare
savings
programs
can help you pay Part A and Part B premiums, deductibles, copays, and coinsurance. To qualify, your income and household resources must be at or below specified limits ...
Health Affairs
8d
A Stronger Medicare Program—Now And Into The Future
As our population continues to age, Medicare’s role in the American health care system continues to grow. And Medicare’s ...
17h
Biden's Medicaid director shares lessons learned and concerns for the program's future
Dan Tsai discusses how he ran Medicaid under Biden, and his fears for how Republicans might try to change the program.
WISH-TV
10h
Braun administration tells providers to stop advertising Medicaid programs
Indiana Family and Social Services Administration instructs MCEs to halt all radio and TV advertising of Indiana Medicaid ...
2d
on MSN
Some parents could be able to join Georgia’s Medicaid program without working
Georgia Gov. Brian Kemp wants to let low-income parents with young kids enroll without working in a Medicaid program that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Ozempic
Wegovy
Feedback